Showing 81-90 of 666 results for "".
Maximizing Valuation and Outcomes for Practice Owners: A Conversation with Dana Jacoby
https://practicaldermatology.com/topics/practice-management/maximizing-valuation-and-outcomes-for-practice-owners-a-conversation-with-dana-jacoby/29889/Contributor Clint Bundy recently interviewed Dana Jacoby, President and CEO of Vector Medical Group, an operational and strategic consulting firm focused on the healthcare sector, to discuss building value in a dermatology and aesthetics practice and optimal ways to achieve full value for that businPsoriasis and Cancer: Is There a Link?
https://practicaldermatology.com/topics/psoriasis/psoriasis-and-cancer-is-there-a-link/23155/New data adds to the evidence for a link between psoriasis and certain cancers, including skin cancer.Investigating the Potential for Neuromodulators in the Treatment of Psoriasis
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/investigating-the-potential-for-neuromodulators-in-the-treatment-of-psoriasis/21398/SDRIFE Induced by Liposomal Daunorubicin and Cytarabine
https://practicaldermatology.com/youngmd-connect/resident-resource-center/sdrife-induced-by-liposomal-daunorubicin-and-cytarabine/20830/Treating Psoriasis with FDA-Approved Medications in 2020
https://practicaldermatology.com/topics/psoriasis/treating-psoriasis-with-fda-approved-medications-in-2020/23212/A reference for all of the FDA-approved medications separated into topical treatments and systemic treatments.First Reported Case of Red Face Response to Tralokinumab in the United States
https://practicaldermatology.com/issues/september-2025/first-reported-case-of-red-face-response-to-tralokinumab-in-the-united-states/37639/The chronic nature of atopic dermatitis (AD), which currently affects approximately 10.8% of children and 7.3% of adults in the United States,1 makes long-term management challenging.Scurvy in the Modern Era
https://practicaldermatology.com/topics/general-topics/scurvy-in-the-modern-era/21456/One of the winning presentations given by dermatology residents at Cosmetic Surgery Forum.Proton Pump Inhibitor-induced Dermal Hypersensitivity Reaction Masquerading as an Arthropod-bite Reaction
https://practicaldermatology.com/youngmd-connect/resident-resource-center/proton-pump-inhibitor-induced-dermal-hypersensitivity-reaction-masquerading-as-an-arthropod-bite-reaction/23940/The Future of Atopic Dermatitis Therapy
https://practicaldermatology.com/topics/general-topics/the-future-of-atopic-dermatitis-therapy/21143/As new research elucidates the individual mechanisms of atopic dermatitis, the development of therapies that more directly influence the disease may change the scope of treatment.Therapies in Practice: New Options for Ichthyosis Vulgaris
https://practicaldermatology.com/topics/general-topics/therapies-in-practice-new-options-for-ichthyosis-vulgaris/21933/Emerging data confirm that atopic dermatitis and ichthyosis share pathogenic traits, suggesting a role for barrier repair formulations in management.